Characterization of inpatient moyamoya in the United States: 1988-2004
- PMID: 21772827
- PMCID: PMC3131528
- DOI: 10.3389/fneur.2011.00043
Characterization of inpatient moyamoya in the United States: 1988-2004
Abstract
Background and purpose: Moyamoya disease has been classically described by the Asian experience, yet clinical aspects of moyamoya phenomena in the United States remain vastly undefined. The multifocal occlusive arterial disorder may be linked with numerous conditions; however, later stages of this syndrome share common vascular pathophysiology. This study is aimed at characterizing inpatient moyamoya cases in the United States over a broad time span.
Methods: A comprehensive analysis of the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project (Releases 1-13, 1988-2004) based on ICD-9-CM code 437.5 was performed. Annual percentages and trends analyses were conducted for demographic variables, admission characteristics, co-morbidities, and procedures.
Result: 2247 admissions of moyamoya cases were analyzed from a wide geographic distribution throughout the United States between 1988 and 2004. Age at admission varied considerably (mean 29.6 ± 18.5 years), affecting women more frequently than men (61.9%). Various racial groups were identified (35.4% White, 19.7% African American, 5.6% Hispanic, 8.3% Asian or Pacific Islander, 1.4% Native American). Admissions were typically emergent (38.8%) or urgent (18.7%), although elective admissions occurred (24.4%). Aside from moyamoya, sickle cell disease was diagnosed in 13.6%, ischemic stroke in 20.7%, intracerebral hemorrhage in 7.4%, transient ischemic attack in 3.4%, and subarachnoid hemorrhage in 3.1%. Cerebral angiography was performed in 24.9% while extracranial-intracranial bypass was done in 8.4% of patients.
Conclusion: Moyamoya in the United States is a heterogeneous condition affecting individuals of all ages across a diverse racial spectrum and wide geographic distribution. Further recognition of moyamoya syndrome may facilitate ongoing research and future therapeutic approaches.
Keywords: cerebral ischemia; collateral; moyamoya; stroke.
Figures
Similar articles
-
National trends in cerebral bypass surgery in the United States, 2002-2014.Neurosurg Focus. 2019 Feb 1;46(2):E4. doi: 10.3171/2018.11.FOCUS18530. Neurosurg Focus. 2019. PMID: 30717065
-
Moyamoya disorder in the United States.Neurosurgery. 2012 Jul;71(1):93-9. doi: 10.1227/NEU.0b013e318253ab8e. Neurosurgery. 2012. PMID: 22418580
-
Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States.J Neurol Sci. 2020 Dec 15;419:117165. doi: 10.1016/j.jns.2020.117165. Epub 2020 Oct 2. J Neurol Sci. 2020. PMID: 33059298
-
Moyamoya disease in children.Childs Nerv Syst. 2010 Oct;26(10):1297-308. doi: 10.1007/s00381-010-1209-8. Epub 2010 Jul 4. Childs Nerv Syst. 2010. PMID: 20607248 Review.
-
[Moyamoya disease: Diagnosis, clinical features, evolution and treatment in 10 patients].Rev Neurol (Paris). 2015 Jan;171(1):58-64. doi: 10.1016/j.neurol.2014.10.013. Epub 2014 Dec 30. Rev Neurol (Paris). 2015. PMID: 25555852 Review. French.
Cited by
-
Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis.Front Neurol. 2023 Mar 2;14:1128338. doi: 10.3389/fneur.2023.1128338. eCollection 2023. Front Neurol. 2023. PMID: 36937514 Free PMC article.
-
Ethnic-Associated Phenotype Variations in Moyamoya Cerebrovascular Outcomes.Cerebrovasc Dis. 2023;52(5):519-525. doi: 10.1159/000528055. Epub 2022 Dec 23. Cerebrovasc Dis. 2023. PMID: 36566750 Free PMC article.
-
Epidemiology of Moyamoya disease in China: A nationwide hospital-based study.Lancet Reg Health West Pac. 2021 Dec 11;18:100331. doi: 10.1016/j.lanwpc.2021.100331. eCollection 2022 Jan. Lancet Reg Health West Pac. 2021. PMID: 35024660 Free PMC article.
-
Western Moyamoya Phenotype: A Scoping Review.Cureus. 2021 Nov 22;13(11):e19812. doi: 10.7759/cureus.19812. eCollection 2021 Nov. Cureus. 2021. PMID: 34956795 Free PMC article. Review.
-
Treatment course and outcomes after revascularization surgery for moyamoya disease in adults.J Neurol. 2018 Nov;265(11):2666-2671. doi: 10.1007/s00415-018-9044-z. Epub 2018 Sep 8. J Neurol. 2018. PMID: 30196325
References
LinkOut - more resources
Full Text Sources
